|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0009566,
umls-concept:C0013931,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0221464,
umls-concept:C0442711,
umls-concept:C0456387,
umls-concept:C0796679,
umls-concept:C1623038,
umls-concept:C1707391,
umls-concept:C2239176
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-6-26
|
|
pubmed:abstractText |
To assess the safety of transarterial treatments of hepatocellular carcinoma (HCC), and the statistical correlation of various patient factors with the frequency of complications, in selected patients with cirrhosis when adhering to well-standardized protocols.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1535-7732
|
|
pubmed:author |
pubmed-author:BiondoDomenicoD,
pubmed-author:D'AntoniAdeleA,
pubmed-author:Fili'DanielaD,
pubmed-author:GridelliBrunoB,
pubmed-author:LucaAngeloA,
pubmed-author:MaruzzelliLuigiL,
pubmed-author:MiragliaRobertoR,
pubmed-author:PetridisIoannisI,
pubmed-author:PietrosiGiadaG,
pubmed-author:VizziniGiovanni BattistaGB,
pubmed-author:VolpesRiccardoR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
896-902
|
|
pubmed:meshHeading |
pubmed-meshheading:19497762-Adult,
pubmed-meshheading:19497762-Aged,
pubmed-meshheading:19497762-Aged, 80 and over,
pubmed-meshheading:19497762-Antibiotics, Antineoplastic,
pubmed-meshheading:19497762-Carcinoma, Hepatocellular,
pubmed-meshheading:19497762-Chemoembolization, Therapeutic,
pubmed-meshheading:19497762-Comorbidity,
pubmed-meshheading:19497762-Dose-Response Relationship, Drug,
pubmed-meshheading:19497762-Epirubicin,
pubmed-meshheading:19497762-Female,
pubmed-meshheading:19497762-Fibrosis,
pubmed-meshheading:19497762-Humans,
pubmed-meshheading:19497762-Italy,
pubmed-meshheading:19497762-Liver Neoplasms,
pubmed-meshheading:19497762-Male,
pubmed-meshheading:19497762-Middle Aged,
pubmed-meshheading:19497762-Prevalence,
pubmed-meshheading:19497762-Risk Assessment,
pubmed-meshheading:19497762-Risk Factors,
pubmed-meshheading:19497762-Survival Analysis,
pubmed-meshheading:19497762-Survival Rate,
pubmed-meshheading:19497762-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
|
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center, Via Tricomi 1, 90127 Palermo, Italy. gpietrosi@ismett.edu
|
|
pubmed:publicationType |
Journal Article
|
